8-Phenyloctanoic acidCAS# 26547-51-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 26547-51-3 | SDF | Download SDF |
PubChem ID | 520273 | Appearance | Powder |
Formula | C14H20O2 | M.Wt | 220.3 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 8-phenyloctanoic acid | ||
SMILES | C1=CC=C(C=C1)CCCCCCCC(=O)O | ||
Standard InChIKey | VZECIAZMSHBQOC-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C14H20O2/c15-14(16)12-8-3-1-2-5-9-13-10-6-4-7-11-13/h4,6-7,10-11H,1-3,5,8-9,12H2,(H,15,16) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
8-Phenyloctanoic acid Dilution Calculator
8-Phenyloctanoic acid Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.5393 mL | 22.6963 mL | 45.3926 mL | 90.7853 mL | 113.4816 mL |
5 mM | 0.9079 mL | 4.5393 mL | 9.0785 mL | 18.1571 mL | 22.6963 mL |
10 mM | 0.4539 mL | 2.2696 mL | 4.5393 mL | 9.0785 mL | 11.3482 mL |
50 mM | 0.0908 mL | 0.4539 mL | 0.9079 mL | 1.8157 mL | 2.2696 mL |
100 mM | 0.0454 mL | 0.227 mL | 0.4539 mL | 0.9079 mL | 1.1348 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Apiin
Catalog No.:BCN2311
CAS No.:26544-34-3
- (-)-Hinokinin
Catalog No.:BCN3227
CAS No.:26543-89-5
- Ryuvidine
Catalog No.:BCC7432
CAS No.:265312-55-8
- GW 7647
Catalog No.:BCC7150
CAS No.:265129-71-3
- Fosaprepitant dimeglumine salt
Catalog No.:BCC4954
CAS No.:265121-04-8
- Taiwanhomoflavone A
Catalog No.:BCN6853
CAS No.:265120-00-1
- N-[Bis(methylthio)methylene]- p-toluenesulfonamide
Catalog No.:BCC9069
CAS No.:2651-15-2
- Methyleugenolglycol
Catalog No.:BCN6562
CAS No.:26509-45-5
- Z-Gln-OH
Catalog No.:BCC2783
CAS No.:2650-64-8
- Nandrolone laurate
Catalog No.:BCC9088
CAS No.:26490-31-3
- Clovanediol diacetate
Catalog No.:BCN5144
CAS No.:2649-68-5
- Clovanediol
Catalog No.:BCN5143
CAS No.:2649-64-1
- 2,3-Dihydroxy-12-oleanen-28-oic acid
Catalog No.:BCN5145
CAS No.:26563-68-8
- 3-Hydroxycatalponol
Catalog No.:BCN5146
CAS No.:265644-24-4
- Z-D-Glu-OMe
Catalog No.:BCC2773
CAS No.:26566-11-0
- Alisol C monoacetate
Catalog No.:BCN2345
CAS No.:26575-93-9
- Alisol B 23-acetate
Catalog No.:BCN1243
CAS No.:26575-95-1
- 5-Acetoacetlamino benzimdazolone
Catalog No.:BCC8725
CAS No.:26576-46-5
- Harmalacidine
Catalog No.:BCN8033
CAS No.:26579-69-1
- Dehydrocrenatine
Catalog No.:BCN5147
CAS No.:26585-13-7
- Crenatine
Catalog No.:BCN5148
CAS No.:26585-14-8
- SCH 202676 hydrobromide
Catalog No.:BCC7049
CAS No.:265980-25-4
- Z-D-Ala-OH
Catalog No.:BCC3059
CAS No.:26607-51-2
- 3-Ethoxyandrosta-3,5-dien-17β-ol
Catalog No.:BCC8631
CAS No.:26614-48-2
Microbial synthesis of poly(beta-hydroxyalkanoates) bearing phenyl groups from pseudomonas putida: chemical structure and characterization.[Pubmed:11749221]
Biomacromolecules. 2001 Summer;2(2):562-7.
New poly(beta-hydroxyalkanoates) having aromatics groups (so-called PHPhAs) from a microbial origin have been characterized. These polymers were produced and accumulated as reserve materials when a beta-oxidation mutant of Pseudomonas putida U, disrupted in the gene that encodes the 3-ketoacyl-CoA thiolase (fadA), was cultured in a chemically defined medium containing different aromatic fatty acids (6-phenylhexanoic acid, 7-phenylheptanoic acid, a mixture of them, or 8-Phenyloctanoic acid) as carbon sources. The polymers were extracted from the bacteria, purified and characterized by using (13)C nuclear magnetic resonance spectroscopy (NMR), gel permeation chromatography (GPC), and differential scanning calorimetry (DSC). Structural studies revealed that when 6-phenylhexanoic acid was added to the cultures, an homopolymer (poly-3-hydroxy-6-phenylhexanoate) was accumulated. The feeding with 8-Phenyloctanoic acid and 7-phenylheptanoic acid leads to the formation of copolymers of the corresponding units with the n - 2 carbons formed after deacetylation, copoly(3-hydroxy-8-phenyloctanoate-3-hydroxy-6-phenylhexanoate) and copoly(3-hydroxy-7-phenylheptanoate-3-hydroxy-5-phenylvalerate), respectively. The mixture of 6-phenylhexanoic acid and 7-phenylheptanoic acid gave rise to the corresponding terpolymer, copoly(3-hydroxy-7-phenylheptanoate-3-hydroxy-6-phenylhexanoate-3-hydroxy-5-pheny lvalerate). Studies on the chemical structure of these three polyesters revealed that they were true copolymers but not a mixture of homopolymers and that the different monomeric units were randomly incorporated in the macromolecular chains. Thermal behavior and molecular weight distribution were also discussed. These compounds had a dual attractive interest in function of (i) their broad use as biodegradable polymers and (ii) their possible biomedical applications.
Aerobic catabolism of phenylacetic acid in Pseudomonas putida U: biochemical characterization of a specific phenylacetic acid transport system and formal demonstration that phenylacetyl-coenzyme A is a catabolic intermediate.[Pubmed:8002592]
J Bacteriol. 1994 Dec;176(24):7667-76.
The phenylacetic acid transport system (PATS) of Pseudomonas putida U was studied after this bacterium was cultured in a chemically defined medium containing phenylacetic acid (PA) as the sole carbon source. Kinetic measurement was carried out, in vivo, at 30 degrees C in 50 mM phosphate buffer (pH 7.0). Under these conditions, the uptake rate was linear for at least 3 min and the value of Km was 13 microM. The PATS is an active transport system that is strongly inhibited by 2,4-dinitrophenol, 4-nitrophenol (100%), KCN (97%), 2-nitrophenol (90%), or NaN3 (80%) added at a 1 mM final concentration (each). Glucose or D-lactate (10 mM each) increases the PATS in starved cells (140%), whereas arsenate (20 mM), NaF, or N,N'-dicyclohexylcarbodiimide (1 mM) did not cause any effect. Furthermore, the PATS is insensitive to osmotic shock. These data strongly suggest that the energy for the PATS is derived only from an electron transport system which causes an energy-rich membrane state. The thiol-containing compounds mercaptoethanol, glutathione, and dithiothreitol have no significant effect on the PATS, whereas thiol-modifying reagents such as N-ethylmaleimide and iodoacetate strongly inhibit uptake (100 and 93%, respectively). Molecular analogs of PA with a substitution (i) on the ring or (ii) on the acetyl moiety or those containing (iii) a different ring but keeping the acetyl moiety constant inhibit uptake to different extents. None of the compounds tested significantly increase the PA uptake rate except adipic acid, which greatly stimulates it (163%). The PATS is induced by PA and also, gratuitously, by some phenyl derivatives containing an even number of carbon atoms on the aliphatic moiety (4-phenyl-butyric, 6-phenylhexanoic, and 8-Phenyloctanoic acids). However, similar compounds with an odd number of carbon atoms (benzoic, 3-phenylpropionic, 5-phenylvaleric, 7-phenylheptanoic, and 9-phenylnonanoic acids) as well as many other PA derivatives do not induce the system, suggesting that the true inducer molecule is phenylacetyl-coenzyme A (PA-CoA). Furthermore, after P. putida U is cultured in the same medium containing other carbon sources (glucose or octanoic, benzoic, or 4-hydroxyphenylacetic acid) in the place of PA, the PATS and PA-CoA are not detected; neither the PATS nor PA-CoA is found in cases in which mutants (PA- and PCL-) lacking the enzyme which catalyzed the initial step of the PA degradation (phenylacetyl-CoA ligase) are used. PA-CoA has been extracted from bacteria and identified as a true PA catabolite by high-performance liquid chromatography and also enzymatically with pure acyl-CoA:6-aminopenicillanic acid acyltransferase from Penicillium chrysogenum.
[Determination of lipase with 8-phenyloctanoic acid vinyl ester as the substrate].[Pubmed:7142919]
J Clin Chem Clin Biochem. 1982 Sep;20(9):627-32.
The UV-test described by Myrick ((1976) Ph. D. Thesis, Birmingham, AL, USA) for the determination of the catalytic activity of lipase in serum, using 8-Phenyloctanoic acid vinyl ester as substrate, was investigated in detail. When tested with sera the assay gave unsatisfactory linearity. For some serum samples, evaluation was impossible, owing to the complete lack of a linear response. The substrate is attacked not only by purified pancreatic lipase, but also by liver esterase, cholinesterase in plasma, and lipoproteinlipase. Attempts to inhibit the interfering esterases with phenylmethylsulphonylfluoride were unsuccessful. Analyses of 102 sera showed no correlation with the results from the titrimetric assay (r = 0.158). Thus the method of Myrick does not provide clinically useful results.